Farms.com Home   News

CattleCon24 in Orlando - A Blend of Industry Insights and Family Fun

CattleCon24 is gearing up to welcome cattle producers and their families to Orlando from Jan. 31 to Feb. 2, 2024. This event is a perfect blend of industry education and family enjoyment. The pre-event Grazing Management Workshop on Jan. 30 will offer valuable insights into pasture management and technology. 

The conference kicks off with Buzz Brainard and includes an inspirational talk by former football player and magician Jon Dorenbos. Expert speakers like futurist Jim Carroll will address the Beef Quality Assurance program, sharing insights on the cattle industry's future. 

Highlights include CattleFax's U.S. & Global Protein and Grain Outlook Session and the 31st annual Cattlemen’s College, focusing on innovative agricultural topics. The event also features updates on D.C. issues and a Sustainability Forum. 

Entertainment is a key aspect of CattleCon24. Attendees will enjoy performances by Anna Sponheim, Paul Bogart, and The Bellamy Brothers. The event's trade show area spans over eight acres, showcasing numerous exhibitors. 

Important meetings for NCBA policy and Beef Checkoff programs will also occur, involving various industry stakeholders. Additional perks include discounted tickets to local theme parks and cruise options. 

For cattle producers, Cattlemen’s College offers the Rancher Resilience Grant, covering registration and accommodation for the first 75 applicants. Don't miss this opportunity to gain industry insights while creating lasting family memories at CattleCon24. 


Trending Video

New discovery may lead to better vaccines for pork producers

Video: New discovery may lead to better vaccines for pork producers



Porcine reproductive and respiratory syndrome virus (PRRSV) causes severe disease in pigs, leading to significant economic losses for pork producers across the globe. It’s estimated that PRRS costs the Canadian pork industry $130M annually. Using the CMCF beamline, researchers from the University of Manitoba and the Leiden University Medical Centre (Netherlands) were able to see the structure of the PRRSV protease, a type of protein the pathogen uses to suppress a host’s immune system. The vital information they uncovered can be used to develop new vaccines against PRRSV and also helps inform development of vaccines against emerging human viruses.